Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Jomaa

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Leukocyte Biology|February 8, 2006
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cellsNadia Caccamo, Francesco Dieli, Daniela Wesch, et al.
Bioorganic & Medicinal Chemistry|January 30, 2002
Anti-malarial activity of N(6)-substituted adenosine derivatives. Part IAbolfasl Golisade, Jochen Wiesner, Claudia Herforth, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycinJochen Wiesner, Dajana Henschker, David B Hutchinson, et al.
Journal of Bacteriology|February 23, 2010
The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by DxsAmanda C Brown, Matthias Eberl, Dean C Crick, et al.
Archiv Der Pharmazie|September 7, 2007
Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residuesRegina Ortmann, Jochen Wiesner, Katrin Silber, et al.
Journal of Leukocyte Biology|October 23, 2004
Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1)Matthias Eberl, Rosel Engel, Silke Aberle, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Structure-activity relationships of novel anti-malarial agents. Part 4: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amidesJochen Wiesner, Andreas Mitsch, Pia Wissner, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katja Kettler, Jacek Sakowski, et al.
Infection and Immunity|July 24, 2004
Mycoplasma penetrans is capable of activating V gamma 9/V delta 2 T cells while other human pathogenic mycoplasmas fail to do soMatthias Eberl, Martin Hintz, Zandraa Jamba, et al.
Journal of Combinatorial Chemistry|July 9, 2002
Antimalarial activity of n(6)-substituted adenosine derivatives (part 2)Claudia Herforth, Jochen Wiesner, Stephan Franke, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Leukocyte Biology|February 8, 2006
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cellsNadia Caccamo, Francesco Dieli, Daniela Wesch, et al.
Bioorganic & Medicinal Chemistry|January 30, 2002
Anti-malarial activity of N(6)-substituted adenosine derivatives. Part IAbolfasl Golisade, Jochen Wiesner, Claudia Herforth, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycinJochen Wiesner, Dajana Henschker, David B Hutchinson, et al.
Journal of Bacteriology|February 23, 2010
The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by DxsAmanda C Brown, Matthias Eberl, Dean C Crick, et al.
Archiv Der Pharmazie|September 7, 2007
Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residuesRegina Ortmann, Jochen Wiesner, Katrin Silber, et al.
Journal of Leukocyte Biology|October 23, 2004
Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1)Matthias Eberl, Rosel Engel, Silke Aberle, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Structure-activity relationships of novel anti-malarial agents. Part 4: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amidesJochen Wiesner, Andreas Mitsch, Pia Wissner, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katja Kettler, Jacek Sakowski, et al.
Infection and Immunity|July 24, 2004
Mycoplasma penetrans is capable of activating V gamma 9/V delta 2 T cells while other human pathogenic mycoplasmas fail to do soMatthias Eberl, Martin Hintz, Zandraa Jamba, et al.
Journal of Combinatorial Chemistry|July 9, 2002
Antimalarial activity of n(6)-substituted adenosine derivatives (part 2)Claudia Herforth, Jochen Wiesner, Stephan Franke, et al.
Pageof 8